In 2014, the Immunosuppressive Drugs Scientific Committee of the International Association
of Therapeutic Drug Monitoring and Clinical Toxicology called a meeting of international …

The mammalian target of rapamycin (mTOR) inhibitors sirolimus and everolimus are
increasingly used in cardiothoracic transplantation. Several recent clinical trials have …

Abstract mTOR inhibitors represent a relatively new therapeutic option in the management of
patients affected by tuberous sclerosis complex (TSC). Randomized clinical trials support …

Background Corticosteroid withdrawal (CW) after pediatric kidney transplantation potentially
improves growth while avoiding metabolic and other adverse events. We have recently …

During the last 5 decades, liver transplantation has witnessed rapid development in terms of
both technical and pharmacologic advances. Since their discovery, calcineurin inhibitors …

The mammalian target of the rapamycin (mTOR) inhibitors sirolimus and everolimus are
increasingly being used in pediatric kidney transplantation in different combinations and …

Controlled trials of m TOR inhibitors in children following solid organ transplantation are
scarce, although evidence from prospective single‐arm studies is growing. Everolimus with …

Long‐term corticosteroid treatment impairs growth in children after kidney transplantation
(KTx). The impact of steroid withdrawal with respect to adult height remains to be elucidated …

Post-transplant lymphoproliferative disease (PTLD) is the most frequent malignant
complication of transplantation in childhood. Even with modern post-transplant …

Abstract In a 24‐month, multicenter, single‐arm, prospective study, 56 pediatric liver
transplant patients with or without basiliximab induction were converted at 1‐6 months post …